Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2

Yasuhiro Maejima1, Shiori Kyoi, Peiyong Zhai

  • 11] Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA. [2] Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Nature Medicine
|October 22, 2013
PubMed

Insights

The proapoptotic kinase Mst1 inhibits autophagy, a key protein quality control process in the heart. This leads to cardiac dysfunction and dilated cardiomyopathy by disrupting the Beclin1-Bcl-2-Bax interaction.

Area of Science:

  • Cardiovascular Biology
  • Cellular Mechanisms
  • Molecular Cardiology

Background:

  • Protein quality control is crucial for cardiac function.
  • Autophagy, a cellular degradation process, is vital for maintaining heart health.
  • Dysregulation of autophagy is implicated in cardiac diseases.

Purpose of the Study:

  • To investigate the role of Mst1 kinase in cardiac protein quality control.
  • To elucidate the mechanism by which Mst1 affects autophagy in cardiomyocytes.
  • To determine the link between Mst1, autophagy, and cardiac dysfunction.

Main Methods:

  • Studied Mst1 activation in cardiomyocytes under stress.
  • Analyzed p62, aggresome, and autophagosome levels.
  • Investigated Mst1 phosphorylation of Beclin1 at Thr108.
  • Assessed interactions between Beclin1, Bcl-2, Bcl-xL, and Bax.
  • Examined cardiac function in Mst1-manipulated mice and human dilated cardiomyopathy patients.

Main Results:

  • Mst1 activation inhibited autophagy and promoted aggresome formation.
  • Mst1 phosphorylated Beclin1 at Thr108, enhancing Beclin1-Bcl-2/Bcl-xL interaction and inhibiting autophagy.
  • Mst1-induced Beclin1 sequestration of Bcl-2/Bcl-xL activated Bax, promoting apoptosis.
  • Mst1 inhibition of autophagy correlated with cardiac dysfunction in myocardial infarction mice.
  • Increased Thr108-phosphorylated Beclin1 and suppressed autophagy were observed in human dilated cardiomyopathy.

Conclusions:

  • Mst1 impairs cardiac protein quality control by inhibiting autophagy.
  • Mst1 phosphorylation of Beclin1 at Thr108 is a key mechanism linking Mst1 to autophagy and apoptosis.
  • Mst1 represents a potential therapeutic target for cardiac diseases associated with autophagic dysfunction.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K